BAUSCH + LOMB CORP
BAUSCH + LOMB CORP
Share · CA0717051076 · BLCO (XTSE)
Overview
Analyst Grade Summary
gauge-img
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
0
5
8
1
0
No Price
Closing Price XTSE 08.12.2025: 23,02 CAD
12.12.2025 20:59
Current Prices from BAUSCH + LOMB CORP
ExchangeTickerCurrencyLast TradePriceDaily Change
XNYS: NYSE
NYSE
BLCO
USD
12.12.2025 20:59
16,97 USD
-0,30 USD
-1,74 %
XFRA: Frankfurt
Frankfurt
S2L.F
EUR
12.12.2025 14:29
14,10 EUR
0,20 EUR
+1,44 %
XDQU: Quotrix
Quotrix
BLCRSN76.DUSD
EUR
12.12.2025 06:27
14,80 EUR
0,90 EUR
+6,47 %
XDUS: Düsseldorf
Düsseldorf
BLCRSN76.DUSB
EUR
11.12.2025 18:32
14,40 EUR
0,80 EUR
+5,88 %
XTSE: TSX
TSX
BLCO.TO
CAD
08.12.2025 20:40
23,02 CAD
-0,59 CAD
-2,50 %
Share Float & Liquidity
Free Float 10,74 %
Shares Float 38,04 M
Shares Outstanding 354,19 M
Company Profile for BAUSCH + LOMB CORP Share
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.
Get up to date insights from finAgent about BAUSCH + LOMB CORP

Company Data

Name BAUSCH + LOMB CORP
Company Bausch + Lomb Corporation
Symbol BLCO
Website https://www.bausch.com
Primary Exchange XTSE TSX
ISIN CA0717051076
Asset Class Share
Sector Healthcare
Industry Medical - Instruments & Supplies
CEO Brenton L. Saunders
Market Capitalization 8 Mrd.
Country Canada
Currency CAD
Employees 13,5 T
Address 520 Applewood Crescent, L4K 4B4 Vaughan
IPO Date 2022-05-06

Ticker Symbols

Name Symbol
Düsseldorf BLCRSN76.DUSB
Frankfurt S2L.F
NYSE BLCO
Quotrix BLCRSN76.DUSD
TSX BLCO.TO
More Shares
Investors who hold BAUSCH + LOMB CORP also have the following shares in their portfolio:
Integrated Capital Services Limited
Integrated Capital Services Limited Share
WRNTS LKD ORDS KS OILS 11/04/2022
WRNTS LKD ORDS KS OILS 11/04/2022 Verbriefte Derivate
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025